E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 9/12/2013 in the Prospect News PIPE Daily.

TNI BioTech completes $531,250 private placement of common shares

465,000 common shares sold in deal at $1.25 per share, $1.00 per share

By Devika Patel

Knoxville, Tenn., Sept. 12 - TNI BioTech, Inc. settled a $531,250 private placement of stock on Sept. 6, according to an 8-K filed Thursday with the Securities and Exchange Commission.

The company sold 465,000 shares at $1.25 per share and $1.00 per share. The prices per share are respective 30.56% and 44.44% discounts to the Sept. 5 closing share price of $1.80.

The Bethesda, Md., company develops immunotherapy products and technologies.

Issuer:TNI BioTech, Inc.
Issue:Common stock
Amount:$531,250
Shares:465,000
Price:$1.25, $1.00
Warrants:No
Settlement date:Sept. 6
Stock symbol:OTCBB: TNIB
Stock price:$1.80 at close Sept. 5
Market capitalization:$60.06 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.